Saad Shakir

InstitutionUniversity of Portsmouth
AddressPortsmouth
United Kingdom
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 6 Covid-19 publications, with a maximum of 2 publications in November 2020
    All Publications
    Bar chart showing 88 publications over 19 distinct years, with a maximum of 10 publications in 2007
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Osborne V, Shakir SAW. What Is the Difference Between Observed Association and Causal Association, Signals and Evidence? Examples Related to COVID-19. Front Pharmacol. 2020; 11:569189. PMID: 33584254.
      Citations:    
    2. Shakir S, Lane S, Davies M. How to Investigate a Serious Adverse Event Reported During a Clinical Trial for a COVID-19 Vaccine. Drug Saf. 2021 01; 44(1):1-5. PMID: 33219926.
      Citations:    Fields:    Translation:Humans
    3. Sultana J, Crisafulli S, Gabbay F, Lynn E, Shakir S, Trifirò G. Challenges for Drug Repurposing in the COVID-19 Pandemic Era. Front Pharmacol. 2020; 11:588654. PMID: 33240091.
      Citations: 18     
    4. Dhanda S, Osborne V, Lynn E, Shakir S. Postmarketing studies: can they provide a safety net for COVID-19 vaccines in the UK? BMJ Evid Based Med. 2022 02; 27(1):1-6. PMID: 33087452.
      Citations: 8     Fields:    
    5. Osborne V, Davies M, Lane S, Evans A, Denyer J, Dhanda S, Roy D, Shakir S. Lopinavir-Ritonavir in the Treatment of COVID-19: A Dynamic Systematic Benefit-Risk Assessment. Drug Saf. 2020 08; 43(8):809-821. PMID: 32578156.
      Citations: 19     Fields:    Translation:HumansCellsPHPublic Health
    6. Davies M, Osborne V, Lane S, Roy D, Dhanda S, Evans A, Shakir S. Remdesivir in Treatment of COVID-19: A Systematic Benefit-Risk Assessment. Drug Saf. 2020 07; 43(7):645-656. PMID: 32468196.
      Citations: 24     Fields:    Translation:HumansCellsPHPublic Health